Bejar Rafael 4
4 · Aptose Biosciences Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Bejar Rafael
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-01-01+400,000→ 0 totalExercise: $5.67Exp: 2030-12-31→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the options vest on 1/1/2021; the remaining 50% vest as follows: 1/3 on 1/1/2022; 1/3 on 1/1/2023; and 1/3 on 1/1/2024.